Area of research
Rheumatology · Immunology
Research interest
Research focused on Rheumatoid arthritis and Abatacept, with related work in Systemic lupus, Lymphoma, Systemic lupus erythematosus. Notable publications include 'Cancer risk in systemic lupus: An updated international multi-centre cohort study', 'Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers', and 'Lymphoma risk in systemic lupus: effects of disease activity versus treatment'.
Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the ‘JAK-pot’ study)
Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the ‘JAK-pot’ collaboration
Biological Disease-Modifying Antirheumatic Drugs and Osteoporotic Fracture Risk in Patients with Rheumatoid Arthritis: A Danish Cohort Study
The occurrence of multiple treatment switches in axial spondyloarthritis. Results from five Nordic rheumatology registries
OP0231 COMPARATIVE EFFECTIVENESS OF JAK-INHIBITORS, TNF-INHIBITORS, ABATACEPT AND IL-6 INHIBITORS IN AN INTERNATIONAL COLLABORATION OF REGISTERS OF RHEUMATOID ARTHRITIS PATIENTS (THE “JAK-POT” STUDY)
Risk of serious infections in patients with rheumatoid arthritis treated in routine care with abatacept, rituximab and tocilizumab in Denmark and Sweden
Impact of TNF inhibitor therapy on joint replacement rates in rheumatoid arthritis: a matched cohort analysis of BSRBR-RA UK registry data
Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project
Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers
Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registers
Cardiac Abnormalities in Adult Patients With Polymyositis or Dermatomyositis as Assessed by Noninvasive Modalities
Cancer risk in systemic lupus: An updated international multi-centre cohort study
Lymphoma risk in systemic lupus: effects of disease activity versus treatment
Non-Lymphoma Hematological Malignancies in Systemic Lupus Erythematosus